Soft tissue repair — rotator cuff reconstruction, ACL reconstruction, meniscal repair, and tendon augmentation — represents one of the largest and most innovation-active segments in orthopedics. Arthrex is the dominant force in sports medicine soft tissue repair, with a comprehensive portfolio of suture anchors, tenodesis screws, meniscal repair systems, and biological scaffold products. Smith & Nephew and Stryker are the primary competitors in this segment.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Rotator Cuff Repair Technology
• ACL Reconstruction Techniques and Products
• Meniscal Repair Systems
• Suture Anchor Technology
• Tendon Augmentation Scaffolds
• Biologics in Soft Tissue Repair
• Leading Company Programs
Table of Contents
1. Executive Summary
2. Technology Landscape Overview
3. Rotator Cuff Repair Technology
4. ACL Reconstruction Techniques and Products
5. Meniscal Repair Systems
6. Suture Anchor Technology
7. Tendon Augmentation Scaffolds
8. Biologics in Soft Tissue Repair
9. Leading Company Programs
10. Competitive Landscape
11. Strategic Conclusions and Recommendations
12. Appendix
List of Tables
Table 1. Technology Overview and Key Data 2025
Table 2. Rotator Cuff Repair Technology
Table 3. ACL Reconstruction Techniques and Products
Table 4. Meniscal Repair Systems
Table 5. Suture Anchor Technology
Table 6. Tendon Augmentation Scaffolds
Table 7. Biologics in Soft Tissue Repair
Table 8. Leading Company Programs
Table 9. Leading Companies — Technology Investment and Strategy 2025
Table 10. M&A and Partnership Activity 2023-2025
Table 11. Key Risks and Mitigation Strategies
Companies Profiled
Arthrex
DePuy Synthes
Enovis
Exactech
Globus Medical
NuVasive
Smith & Nephew
Stryker
Zimmer Biomet
